{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:52:14Z","timestamp":1780527134522,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/01474"],"award-info":[{"award-number":["PI17\/01474"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/01474"],"award-info":[{"award-number":["PI17\/01474"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>FACEmemory\u00ae is the first computerized, self-administered verbal episodic memory test with voice recognition. It can be conducted under minimal supervision and contains an automatic scoring system to avoid administrator errors. Moreover, it is suitable for discriminating between cognitively healthy and amnestic mild cognitive impairment (MCI) individuals, and it is associated with Alzheimer\u2019s disease (AD) cerebrospinal fluid (CSF) biomarkers. This study aimed to determine whether FACEmemory scoring is related to performance on classical memory tests and to AD biomarkers of brain magnetic resonance imaging (MRI) and CSF in patients with early-onset MCI (EOMCI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Ninety-four patients with EOMCI from the BIOFACE study completed FACEmemory, classical memory tests (the Spanish version of the Word Free and Cued Selective Reminding Test -FCSRT-, the Word List from the Wechsler Memory Scale, third edition, and the Spanish version of the Rey\u2013Osterrieth Complex Figure Test), and a brain MRI. Eighty-two individuals also underwent a lumbar puncture.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>FACEmemory scoring was moderately correlated with FCSRT scoring. With regard to neuroimaging MRI results, worse execution on FACEmemory was associated with lower cortical volume in the right prefrontal and inferior parietal areas, along with the left temporal and associative occipital areas. Moreover, the total FACEmemory score correlated with CSF AD biomarkers (A\u03b21-42\/A\u03b21-40 ratio, p181-tau, and A\u03b21-42\/p181-tau ratio). When performance on FACEmemory was compared among the ATN classification groups, significant differences between the AD group and normal and SNAP groups were found.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>FACEmemory is a promising tool for detecting memory deficits sensitive to early-onset AD, but it also allows the detection of memory-impaired cases due to other etiologies. Our findings suggest that FACEmemory scoring can detect the AD endophenotype and that it is also associated with AD-related changes in MRI and CSF in patients with EOMCI. The computerized FACEmemory tool might be an opportunity to facilitate early detection of MCI in younger people than 65, who have a growing interest in new technologies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-022-00988-8","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T17:02:52Z","timestamp":1647622972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Automatized FACEmemory\u00ae scoring is related to Alzheimer\u2019s disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8164-9500","authenticated-orcid":false,"given":"Montserrat","family":"Alegret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Sotolongo-Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester Esteban","family":"de Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"P\u00e9rez-Cord\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelina","family":"Orellana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sanabria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Roberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maitee","family":"Rosende-Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Tartari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Alarcon-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"de Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Montrreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Morat\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorene M.","family":"Rentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"T\u00e1rraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Marqui\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Boada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"988_CR1","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","volume":"9","author":"B Dubois","year":"2010","unstructured":"Dubois B, Feldman HH, Jacova C, Cummings JL, DeKosky ST, Barberger-Gateau P, et al. Revising the definition of Alzheimer\u2019s disease: a new lexicon. Lancet Neurol. 2010;9:1118\u201327.","journal-title":"Lancet Neurol"},{"key":"988_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/geriatrics1020011","volume":"1","author":"M T\u00e1buas-Pereira","year":"2016","unstructured":"T\u00e1buas-Pereira M, Baldeiras I, Duro D, Santiago B, Ribeiro MH, Leit\u00e3o MJ, et al. Prognos is of early-onset vs. late-onset mild cognitive impairment: comparison of conversion rates and its predictors. Geriatrics. 2016;1:1\u201312.","journal-title":"Geriatrics"},{"key":"988_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183\u201394.","journal-title":"J Intern Med"},{"key":"988_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/alz.12350","volume":"17","author":"LG Apostolova","year":"2021","unstructured":"Apostolova LG, Aisen P, Eloyan A, Fagan A, Fargo KN, Foroud T, et al. The Longitudinal Early-onset Alzheimer\u2019s Disease Study (LEADS): framework and methodology. Alzheimers Dement. 2021;17:1\u201313.","journal-title":"Alzheimers Dement."},{"key":"988_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2017.01.013","volume":"53","author":"PJ Nathan","year":"2017","unstructured":"Nathan PJ, Lim YY, Abbott R, Galluzzi S, Marizzoni M, Babiloni C, et al. Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI). Neurobiol Aging. 2017;53:1\u201310.","journal-title":"Neurobiol Aging"},{"key":"988_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1001\/archneur.64.1.108","volume":"64","author":"C DeCarli","year":"2007","unstructured":"DeCarli C, Frisoni GB, Clark CM, Harvey D, Grundman M, Petersen RC, et al. Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch Neurol. 2007;64:108\u201315.","journal-title":"Arch Neurol"},{"key":"988_CR7","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/brain\/awl377","volume":"130","author":"GB Frisoni","year":"2007","unstructured":"Frisoni GB, Pievani M, Testa C, Sabattoli F, Bresciani L, Bonetti M, et al. The topography of grey matter involvement in early and late onset Alzheimer\u2019s disease. Brain. 2007;130:720\u201330.","journal-title":"Brain"},{"key":"988_CR8","first-page":"34","volume":"25","author":"MF Mendez","year":"2019","unstructured":"Mendez MF. Early-onset Alzheimer disease and its variants. Continuum (Minneap Minn). 2019;25:34\u201351.","journal-title":"Continuum (Minneap Minn)"},{"key":"988_CR9","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1007\/s00415-015-7698-3","volume":"262","author":"A Palas\u00ed","year":"2015","unstructured":"Palas\u00ed A, Guti\u00e9rrez-Iglesias B, Alegret M, Pujadas F, Olabarrieta M, Li\u00e9bana D, et al. Differentiated clinical presentation of early and late-onset Alzheimer\u2019s disease: is 65 years of age providing a reliable threshold? J Neurol. 2015;262:1238\u201346.","journal-title":"J Neurol"},{"key":"988_CR10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614\u201329.","journal-title":"Lancet Neurol"},{"key":"988_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/87565648709540361","volume":"3","author":"E Grober","year":"1987","unstructured":"Grober E, Buschke H, Korey SR. Genuine memory deficits in dementia. Dev Neuropsychol. 1987;3:13\u201336.","journal-title":"Dev Neuropsychol"},{"key":"988_CR12","first-page":"188","volume":"6","author":"E Grober","year":"2017","unstructured":"Grober E, Wakefield D, Ehrlich AR, Mabie P, Lipton RB. Identifying memory impairment and early dementia in primary care. Alzheimers Dement Diagnosis Assess Dis Monit. 2017;6:188\u201395.","journal-title":"Alzheimers Dement Diagnosis Assess Dis Monit"},{"key":"988_CR13","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/mds.21844","volume":"22","author":"B Dubois","year":"2007","unstructured":"Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, et al. Diagnostic procedures for Parkinson\u2019s disease dementia: recommendations from the Movement Disorder Society Task Force. Mov Disord. 2007;22:2314\u201324.","journal-title":"Mov Disord"},{"key":"988_CR14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1212\/WNL.54.4.827","volume":"54","author":"E Grober","year":"2000","unstructured":"Grober E, Lipton RB, Hall C, Crystal H. Memory impairment on free and cued selective reminding predicts dementia. Neurology. 2000;54:827\u201332.","journal-title":"Neurology"},{"key":"988_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-016-0190-1","volume":"8","author":"N Philippi","year":"2016","unstructured":"Philippi N, Noblet V, Duron E, Cretin B, Boully C, Wisniewski I, et al. Exploring anterograde memory: a volumetric MRI study in patients with mild cognitive impairment. Alzheimers Res Ther. 2016;8:1\u201314.","journal-title":"Alzheimers Res Ther."},{"key":"988_CR16","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3233\/JAD-131916","volume":"41","author":"J Xie","year":"2014","unstructured":"Xie J, Gabelle A, Dorey A, Garnier-Crussard A, Perret-Liaudet A, et al. Initial memory deficit profiles in patients with a cerebrospinal fluid Alzheimer\u2019s disease signature. J Alzheimers Dis. 2014;41:1109\u201316.","journal-title":"J Alzheimers Dis"},{"key":"988_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-020-00594-6","volume":"12","author":"M Alegret","year":"2020","unstructured":"Alegret M, Mu\u00f1oz N, Roberto N, Rentz DM, Valero S, Gil S, et al. A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory\u00ae) for the early detection of Alzheimer\u2019s disease. Alzheimers Res Ther. 2020;12:1\u201311.","journal-title":"Alzheimers Res Ther"},{"key":"988_CR18","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/13854046.2014.911351","volume":"28","author":"KV Papp","year":"2014","unstructured":"Papp KV, Amariglio RE, Dekhtyar M, Roy K, Wigman S, Bamfo R, et al. Development of a psychometrically equivalent short form of the face-name associative memory exam for use along the early alzheimers disease trajectory. Clin Neuropsychol. 2014;28:771\u201385.","journal-title":"Clin Neuropsychol"},{"key":"988_CR19","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1080\/13803395.2012.666230","volume":"34","author":"RE Amariglio","year":"2012","unstructured":"Amariglio RE, Frishe K, Olson LE, Wadsworth LP, Lorius N, Sperling RA, et al. Validation of the face name associative memory exam in cognitively normal older individuals. J Clin Exp Neuropsychol. 2012;34:580\u20137.","journal-title":"J Clin Exp Neuropsychol"},{"key":"988_CR20","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1016\/j.neuropsychologia.2011.06.006","volume":"49","author":"DM Rentz","year":"2011","unstructured":"Rentz DM, Amariglio RE, Becker JA, Frey M, Olson LE, Frishe K, et al. Face-name associative memory performance is related to amyloid burden in normal elderly. Neuropsychologia. 2011;49:2776\u201383.","journal-title":"Neuropsychologia"},{"key":"988_CR21","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3233\/JAD-122002","volume":"34","author":"A Espinosa","year":"2013","unstructured":"Espinosa A, Alegret M, Valero S, Vinyes-Junqu\u00e9 G, Hern\u00e1ndez I, Maule\u00f3n A, et al. A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved. J Alzheimers Dis. 2013;34:769\u201380.","journal-title":"J Alzheimers Dis"},{"key":"988_CR22","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1037\/pag0000294","volume":"33","author":"J Oltra-Cucarella","year":"2018","unstructured":"Oltra-Cucarella J, Ferrer-Cascales R, Alegret M, Gasparini R, D\u00edaz-Ortiz LM, R\u00edos R, et al. Risk of progression to Alzheimer\u2019s disease for different neuropsychological mild cognitive impairment subtypes: a hierarchical meta-analysis of longitudinal studies. Psychol Aging. 2018;33:1007\u201321.","journal-title":"Psychol Aging"},{"key":"988_CR23","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3233\/JAD-210254","volume":"83","author":"E Esteban de Antonio","year":"2021","unstructured":"Esteban de Antonio E, Perez-Cordon A, Gil S, Orellana A, Cano A, Alegret M, et al. BIOFACE: a prospective study of risk factors, biomarkers and cognition in a cohort of individuals with early-onset mild cognitive impairment. Study rationale and research protocols. J Alzheimers Dis. 2021;83:1233\u201349.","journal-title":"J Alzheimers Dis"},{"key":"988_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/13803395.2011.630652","volume":"34","author":"M Alegret","year":"2012","unstructured":"Alegret M, Espinosa A, Vinyes-Junqu\u00e9 G, Valero S, Hern\u00e1ndez I, T\u00e1rraga L, et al. Normative data of a brief neuropsychological battery for Spanish individuals older than 49. J Clin Exp Neuropsychol. 2012;34:209\u201319.","journal-title":"J Clin Exp Neuropsychol"},{"key":"988_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0076436","volume":"8","author":"M Alegret","year":"2013","unstructured":"Alegret M, Espinosa A, Valero S, Vinyes-Junqu\u00e9 G, Ruiz A, Hern\u00e1ndez I, et al. Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish individual adults older than 44 years old. PLoS One. 2013;8:1\u20138.","journal-title":"PLoS One"},{"key":"988_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/arclin\/acp041","volume":"24","author":"J Pe\u00f1a-Casanova","year":"2009","unstructured":"Pe\u00f1a-Casanova J, Gramunt-Fombuena N, Qui\u00f1ones-\u00dabeda S, S\u00e1nchez-Benavides G, Aguilar M, Badenes D, et al. Spanish Multicenter Normative Studies (NEURONORMA project): norms for the Rey-Osterrieth complex figure (copy and memory), and free and cued selective reminding test. Arch Clin Neuropsychol. 2009;24:371\u201393.","journal-title":"Arch Clin Neuropsychol"},{"key":"988_CR27","volume-title":"WMS\u2013III. Wechsler Memory Scale\u2013Third Edition. Administration and scoring manual","author":"D Wechsler","year":"1997","unstructured":"Wechsler D. WMS\u2013III. Wechsler Memory Scale\u2013Third Edition. Administration and scoring manual. San Antonio: The Psychological Corporation; 1997."},{"key":"988_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jalz.2011.07.004","volume":"8","author":"H Vanderstichele","year":"2012","unstructured":"Vanderstichele H, Bibl M, Engelborghs S, Le Bastard N, Lewczuk P, Molinuevo JL, et al. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer\u2019s disease diagnosis: a consensus paper from the Alzheimer\u2019s Biomarkers Standardization Initiative. Alzheimers Dement. 2012;8:65\u201373.","journal-title":"Alzheimers Dement"},{"key":"988_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Budd Haeberlein S, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:535\u201362.","journal-title":"Alzheimers Dement"},{"key":"988_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1023\/A:1007413511361","volume":"29","author":"P Domingos","year":"1997","unstructured":"Domingos P, Pazzani M. On the optimality of the simple Bayesian classifier under zero-one loss. Mach Learn. 1997;29:103\u201330.","journal-title":"Mach Learn"},{"key":"988_CR31","volume-title":"ADNIMERGE: Alzheimer\u2019s disease neuroimaging initiative. R package version 0.0.1","author":"The ADNI team","year":"2021","unstructured":"The ADNI team. ADNIMERGE: Alzheimer\u2019s disease neuroimaging initiative. R package version 0.0.1. 2021."},{"key":"988_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1212\/01.wnl.0000287091.57376.65","volume":"70","author":"AS Fleisher","year":"2008","unstructured":"Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC, et al. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology. 2008;70:191\u20139.","journal-title":"Neurology"},{"key":"988_CR33","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s11682-012-9177-0","volume":"6","author":"SD Han","year":"2012","unstructured":"Han SD, Gruhl J, Beckett L, Dodge HH, Stricker NH, Farias S, et al. Beta amyloid, tau, neuroimaging, and cognition: sequence modeling of biomarkers for Alzheimer\u2019s disease. Brain Imaging Behav. 2012;6:610\u201320.","journal-title":"Brain Imaging Behav"},{"key":"988_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/JAD-2012-111850","volume":"30","author":"M Alegret","year":"2012","unstructured":"Alegret M, Cuberas-Borr\u00f3s G, Vinyes-Junqu\u00e9 G, Espinosa A, Valero S, Hern\u00e1ndez I, et al. A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer\u2019s disease. J Alzheimers Dis. 2012;30:109\u201320.","journal-title":"J Alzheimers Dis"},{"key":"988_CR35","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3233\/JAD-161223","volume":"57","author":"A Espinosa","year":"2017","unstructured":"Espinosa A, Alegret M, Pesini P, Valero S, Lafuente A, Buend\u00eda M, et al. Cognitive composites domain scores related to neuroimaging biomarkers within probable-amnestic mild cognitive impairment-storage subtype. J Alzheimers Dis. 2017;57:447\u201359.","journal-title":"J Alzheimers Dis"},{"key":"988_CR36","first-page":"161","volume":"10","author":"E Grober","year":"2018","unstructured":"Grober E, Veroff AE, Lipton RB. Temporal unfolding of declining episodic memory on the Free and Cued Selective Reminding Test in the predementia phase of Alzheimer\u2019s disease: implications for clinical trials. Alzheimers Dement Diagnosis Assess Dis Monit. 2018;10:161\u201371.","journal-title":"Alzheimers Dement Diagnosis Assess Dis Monit"},{"key":"988_CR37","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.bandc.2009.11.007","volume":"72","author":"KHM Chen","year":"2010","unstructured":"Chen KHM, Chuah LYM, Sim SKY, Chee MWL. Hippocampal region-specific contributions to memory performance in normal elderly. Brain Cogn. 2010;72:400\u20137.","journal-title":"Brain Cogn"},{"key":"988_CR38","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S0010-9452(08)70689-0","volume":"43","author":"K Werheid","year":"2007","unstructured":"Werheid K, Clare L. Are faces special in Alzheimer\u2019s disease? Cognitive conceptualisation, neural correlates, and diagnostic relevance of impaired memory for faces and names. Cortex. 2007;43:898\u2013906.","journal-title":"Cortex"},{"key":"988_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-21644-y","volume":"8","author":"A Sanabria","year":"2018","unstructured":"Sanabria A, Alegret M, Rodriguez-Gomez O, Valero S, Sotolongo-Grau O, Mont\u00e9-Rubio G, et al. The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in subjective cognitive decline. Sci Rep. 2018;8:1\u20139.","journal-title":"Sci Rep"},{"key":"988_CR40","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/arclin\/acv050","volume":"30","author":"M Alegret","year":"2015","unstructured":"Alegret M, Valero S, Ortega G, Espinosa A, Sanabria A, Hern\u00e1ndez I, et al. Validation of the Spanish version of the face name associative memory exam (S-FNAME) in cognitively normal older individuals. Arch Clin Neuropsychol. 2015;30:712\u201320.","journal-title":"Arch Clin Neuropsychol"},{"key":"988_CR41","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3233\/JAD-140276","volume":"42","author":"MW Bondi","year":"2014","unstructured":"Bondi MW, Edmonds EC, Jak AJ, Clark LR, Delano-Wood L, McDonald CR, et al. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. J Alzheimers Dis. 2014;42:275\u201389.","journal-title":"J Alzheimers Dis"},{"key":"988_CR42","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.neurobiolaging.2013.02.013","volume":"34","author":"C M\u00f6ller","year":"2013","unstructured":"M\u00f6ller C, Vrenken H, Jiskoot L, Versteeg A, Barkhof F, Scheltens P, et al. Different patterns of gray matter atrophy in early- and late-onset Alzheimer\u2019s disease. Neurobiol Aging. 2013;34:2014\u201322.","journal-title":"Neurobiol Aging"},{"key":"988_CR43","doi-asserted-by":"publisher","first-page":"e512","DOI":"10.1212\/NXG.0000000000000512","volume":"6","author":"C Reitz","year":"2020","unstructured":"Reitz C, Rogaeva E, Beecham GW. Late-onset vs nonmendelian early-onset Alzheimer disease: a distinction without a difference? Neurol Genet. 2020;6:e512.","journal-title":"Neurol Genet"},{"key":"988_CR44","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/1533317512454711","volume":"27","author":"MF Mendez","year":"2012","unstructured":"Mendez MF, Lee AS, Joshi A, Shapira JS. Nonamnestic presentations of early-onset Alzheimer\u2019s disease. Am J Alzheimers Dis Other Demen. 2012;27:413\u201320.","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"988_CR45","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","volume":"25","author":"RL Buckner","year":"2005","unstructured":"Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, et al. Molecular, structural, and functional characterization of Alzheimer\u2019s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci. 2005;25:7709\u201317.","journal-title":"J Neurosci"},{"key":"988_CR46","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.arcmed.2012.11.009","volume":"43","author":"MF Mendez","year":"2012","unstructured":"Mendez MF. Early-onset Alzheimer\u2019s disease: nonamnestic subtypes and type 2 AD. Arch Med Res. 2012;43:677\u201385.","journal-title":"Arch Med Res"},{"key":"988_CR47","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1162\/jocn.2009.21201","volume":"22","author":"JA Mangels","year":"2009","unstructured":"Mangels JA, Manzi A, Summerfield C. The first does the work, but the third time\u2019s the charm: the effects of massed repetition on episodic encoding of multimodal face\u2013name associations. J Cogn Neurosci. 2009;22:457\u201373.","journal-title":"J Cogn Neurosci"},{"key":"988_CR48","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/acn3.274","volume":"3","author":"S Janelidze","year":"2016","unstructured":"Janelidze S, Zetterberg H, Mattsson N, Palmqvist S, Vanderstichele H, Lindberg O, et al. CSF A\u03b242\/A\u03b240 and A\u03b242\/A\u03b238 ratios: better diagnostic markers of Alzheimer disease. Ann Clin Transl Neurol. 2016;3:154\u201365.","journal-title":"Ann Clin Transl Neurol"},{"key":"988_CR49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13195-019-0485-0","volume":"11","author":"O Hansson","year":"2019","unstructured":"Hansson O, Lehmann S, Otto M, Zetterberg H, Lewczuk P. Advantages and disadvantages of the use of the CSF Amyloid \u03b2 (A\u03b2) 42\/40 ratio in the diagnosis of Alzheimer\u2019s disease. Alzheimers Res Ther. 2019;11:34.","journal-title":"Alzheimers Res Ther"},{"key":"988_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-018-0362-2","volume":"10","author":"I Baldeiras","year":"2018","unstructured":"Baldeiras I, Santana I, Leit\u00e3o MJ, Gens H, Pascoal R, T\u00e1buas-Pereira M, et al. Addition of the A\u03b242\/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer\u2019s disease dementia in mild cognitive impairment. Alzheimers Res Ther. 2018;10:1\u201315.","journal-title":"Alzheimers Res Ther"},{"key":"988_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-019-0549-1","volume":"11","author":"V P\u00e9rez-Grijalba","year":"2019","unstructured":"P\u00e9rez-Grijalba V, Arbizu J, Romero J, Prieto E, Pesini P, Sarasa L, et al. Plasma A\u03b242\/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 study. Alzheimers Res Ther. 2019;11:1\u20139.","journal-title":"Alzheimers Res Ther"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-00988-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-022-00988-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-00988-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T21:15:43Z","timestamp":1668201343000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-022-00988-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["988"],"URL":"https:\/\/doi.org\/10.1186\/s13195-022-00988-8","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]},"assertion":[{"value":"9 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The BIOFACE study was approved by the Ethics Committee of Hospital Clinic (Barcelona, Spain). Prior to the evaluation, written informed consent was obtained from all participants. The study was conducted in accordance with the Declaration of Helsinki and with Spanish biomedical laws (Law 14\/2007, July 3, about biomedical research; Royal Decree 1716\/2011, November 18).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}